DAY 5 - Thursday, September 13
Welcome
Ophthalmology Times Europe presents the latest news and views from the final day of the Milan ESCRS Congress. On the last day we reported on lectures about CI-OCT, monovision, a new nomogram and aspheric ablations in myopia. We sampled a few of products on the show floor and asked our final question in the 'Your Thoughts' section.
LATEST LECTURES
CI-OCT, monovision and nomograms
During the final day at the Milan ESCRS 2012, CI-OCT for lamellar corneal surgery, monovision for diplopia, a nomogram for WFG-LASIK and aspheric ablations in myopia were some of the subjects OTEurope covered. » MORE
PRODUCT NEWS
Hydrophobic acrylic IOL
New from PhysIOL is the glistening-free hydrophobic acrylic IOL iPure. Featuring a UV and blue light blocker the iPure is able to control water content at the equilibrium. » MORE
Tissue-sparing laser therapy
Iridex has launched the MicroPulse Laser Therapy with IQ 577 laser and EndoProbe instrumentation, a combination therapy that allows laser surgery to be delivered via an IOL fibre-optic probe. » MORE
YOUR THOUGHTS
After attending this year's ESCRS have you been inspired to change your treatment protocol?
We asked three ESCRS attendees how have they been inspired by this year's ESCRS and here are their answers… » MORE
Closing remarks
We at OTEurope hope you have enjoyed your stay in Milan during this year's ESCRS and have found our meeting briefs to be useful. We will be continuing to cover the exciting and interesting developments from this year's event in upcoming issues so we invite you to keep reading and please do feel free to comment on what we have covered so far.
SOCIAL NETWORKING
Discuss
Join our LinkedIn group, European Ophthalmology, For the latest discussions, jobs, polls and promotions in the ophthalmic community
Follow
Join our 3000 followers and follow us on Twitter to interact with ophthalmologists and industry leaders. You could even be in with a chance of becoming one of our Follow Friday favourites or Tweet of the Week.
Read
Read our blog for the latest outlook on the ophthalmic industry.
Log on
Log on to the OTEurope website for up-to-date news, product profiles, events, surveys and much more.
Subscribe
Subscribe to our weekly e-newsletter for breaking news and the regular survey question. You can also subscribe to the print version of OTEurope by clicking here.
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times Group. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. Some of the products reported in this conference brief may not be FDA approved in the United States.
|
